Annual Current Assets
$486.48 M
+$55.30 M+12.83%
December 31, 2023
Summary
- As of February 20, 2025, VRDN annual total current assets is $486.48 million, with the most recent change of +$55.30 million (+12.83%) on December 31, 2023.
- During the last 3 years, VRDN annual current assets has risen by +$356.87 million (+275.34%).
- VRDN annual current assets is now at all-time high.
Performance
VRDN Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$767.36 M
+$185.69 M+31.92%
September 30, 2024
Summary
- As of February 20, 2025, VRDN quarterly total current assets is $767.36 million, with the most recent change of +$185.69 million (+31.92%) on September 30, 2024.
- Over the past year, VRDN quarterly current assets has increased by +$443.52 million (+136.96%).
- VRDN quarterly current assets is now at all-time high.
Performance
VRDN Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
VRDN Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.8% | +137.0% |
| 3 y3 years | +275.3% | +137.0% |
| 5 y5 years | +644.2% | +137.0% |
VRDN Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +143.0% | at high | +361.8% |
| 5 y | 5-year | at high | +1535.8% | at high | +2480.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Viridian Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $767.36 M(+31.9%) |
| Jun 2024 | - | $581.66 M(-7.2%) |
| Mar 2024 | - | $626.82 M(+28.8%) |
| Dec 2023 | $3.95 M(+0.7%) | $486.48 M(+50.2%) |
| Sep 2023 | - | $323.84 M(-6.5%) |
| Jun 2023 | - | $346.33 M(-9.5%) |
| Mar 2023 | - | $382.60 M(-11.3%) |
| Dec 2022 | $3.92 M(+10.5%) | $431.17 M(-1.4%) |
| Sep 2022 | - | $437.36 M(+163.2%) |
| Jun 2022 | - | $166.15 M(-7.4%) |
| Mar 2022 | - | $179.39 M(-10.4%) |
| Dec 2021 | $3.55 M(+115.7%) | $200.16 M(-8.2%) |
| Sep 2021 | - | $217.94 M(+88.8%) |
| Jun 2021 | - | $115.46 M(-5.0%) |
| Mar 2021 | - | $121.53 M(-6.2%) |
| Dec 2020 | $1.64 M(+214.3%) | $129.61 M(+305.4%) |
| Sep 2020 | - | $31.97 M(-1.7%) |
| Jun 2020 | - | $32.52 M(-15.2%) |
| Mar 2020 | - | $38.34 M(+28.9%) |
| Dec 2019 | $523.00 K | $29.74 M(-22.2%) |
| Sep 2019 | - | $38.22 M(-20.5%) |
| Jun 2019 | - | $48.08 M(-11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $54.21 M(-17.1%) |
| Dec 2018 | $777.00 K(+26.8%) | $65.37 M(-13.7%) |
| Sep 2018 | - | $75.75 M(-6.7%) |
| Jun 2018 | - | $81.22 M(-5.9%) |
| Mar 2018 | - | $86.35 M(+66.5%) |
| Dec 2017 | $613.00 K(>+9900.0%) | $51.87 M(+11.7%) |
| Sep 2017 | - | $46.42 M(-5.9%) |
| Jun 2017 | - | $49.35 M(-13.3%) |
| Mar 2017 | - | $56.94 M(+1236.9%) |
| Dec 2016 | $0.00(-100.0%) | $4.26 M(-34.6%) |
| Sep 2016 | - | $6.51 M(-18.3%) |
| Jun 2016 | - | $7.97 M(-17.6%) |
| Mar 2016 | - | $9.67 M(-17.6%) |
| Dec 2015 | $1.17 M(-10.4%) | $11.73 M(-13.8%) |
| Sep 2015 | - | $13.61 M(+14.7%) |
| Jun 2015 | - | $11.86 M(-18.2%) |
| Mar 2015 | - | $14.49 M(+113.6%) |
| Dec 2014 | $1.30 M(-19.4%) | $6.79 M(-21.6%) |
| Sep 2014 | - | $8.66 M(-11.4%) |
| Jun 2014 | - | $9.77 M(+515.8%) |
| Mar 2014 | - | $1.59 M(-22.8%) |
| Dec 2013 | $1.62 M(+44.8%) | $2.06 M |
| Dec 2012 | $1.12 M | - |
FAQ
- What is Viridian Therapeutics annual total current assets?
- What is the all time high annual current assets for Viridian Therapeutics?
- What is Viridian Therapeutics annual current assets year-on-year change?
- What is Viridian Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly current assets year-on-year change?
What is Viridian Therapeutics annual total current assets?
The current annual current assets of VRDN is $486.48 M
What is the all time high annual current assets for Viridian Therapeutics?
Viridian Therapeutics all-time high annual total current assets is $486.48 M
What is Viridian Therapeutics annual current assets year-on-year change?
Over the past year, VRDN annual total current assets has changed by +$55.30 M (+12.83%)
What is Viridian Therapeutics quarterly total current assets?
The current quarterly current assets of VRDN is $767.36 M
What is the all time high quarterly current assets for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly total current assets is $767.36 M
What is Viridian Therapeutics quarterly current assets year-on-year change?
Over the past year, VRDN quarterly total current assets has changed by +$443.52 M (+136.96%)